Question to the Department of Health and Social Care:

To ask Her Majesty's Government how they plan to ensure that there will remain a multi-supplier market for flu vaccine procurement in future seasons.

The flu vaccine market is complex with multiple manufacturers and products which are recommended for different cohorts. Each year the Joint Committee on Vaccinations and Immunisations makes recommendations on which products should be used for each cohort. New products and technologies are emerging and the Department works closely with the industry to look at the future of flu vaccines. Furthermore, for the 2020/2021 and 2021/2022 seasons, the Department supported the introduction of new, quadrivalent recombinant flu vaccines to diversify the flu vaccine market and ensure a wide range of products are available now and in the future.